Headache
-
Multicenter Study Clinical Trial
A long-term open-label study of oral almotriptan 12.5 mg for the treatment of acute migraine.
Evaluate the long-term tolerability of almotriptan 12.5 mg for the treatment of acute migraine attacks occurring over a 6-month period. ⋯ When taken at attack onset, almotriptan 12.5 mg is well tolerated, safe, and effective for the long-term treatment of acute migraine.